Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon-like peptide-1 (GLP-1) receptor agonist drugs. The stock is up about 36% year to date as of this writing and has gained around 506% over the past five years.

Shares of Eli Lilly & Co. LLY inched 0.50% higher to $781.98 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.26% to 5,942.47 and the Dow Jones Industrial Average DJIA rising 0.80% to 42,732.13.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 478.78% and currently trading at $765.21. The company has been around since 1876 and the stock didn’t go public until 1952 but in the last 4 years,